cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Procept Biorobotics
5 own
6 watching
Current Price
$51.1
$-0.69
(-1.33%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,074.91M
52-Week High
52-Week High
54.50000
52-Week Low
52-Week Low
24.83000
Average Volume
Average Volume
0.56M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization2,074.91M
icon52-Week High54.50000
icon52-Week Low24.83000
iconAverage Volume0.56M
iconDividend Yield--
iconP/E Ratio--
What does the Procept Biorobotics do?
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
Read More
How much money does Procept Biorobotics make?
News & Events about Procept Biorobotics.
Globe Newswire
11 months ago
5-Year results from WATER II when combined with 5-year results from the original WATER study demonstrate that Aquablation therapy provides long-termsymptom relief while preserving sexual function for patients with small and large prostates.The study concluded that Aquablation therapy: Is safe, ...
Ticker Report
1 year ago
PROCEPT BioRobotics Co. (NASDAQ:PRCT Get Rating) has received an average recommendation of Moderate Buy from the nine analysts that are currently covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold rating and six have given a buy ...
Globe Newswire
1 year ago
PROCEPT BioRobotics to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 28, 2023REDWOOD CITY, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the Company), a surgical robotics company focused on advancing patient care by developing ...
Benzinga
1 year ago
Latest Ratings for PRCT DateFirmActionFromTo Mar 2022B of A SecuritiesMaintainsBuy Mar 2022SVB LeerinkMaintainsOutperform Nov 2021SVB LeerinkMaintainsOutperform View More Analyst Ratings for PRCT View the Latest Analyst Ratings read more...
Globe Newswire
1 year ago
REDWOOD CITY, Calif., Oct. 10, 2022 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation(Nasdaq: PRCT) (the Company), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today that it has entered into a new five-year $52 million ...
Frequently Asked Questions
Frequently Asked Questions
What is Procept Biorobotics share price today?
plus_minus_icon
Can Indians buy Procept Biorobotics shares?
plus_minus_icon
How can I buy Procept Biorobotics shares from India?
plus_minus_icon
Can Fractional shares of Procept Biorobotics be purchased?
plus_minus_icon
What are the documents required to start investing in Procept Biorobotics stocks?
plus_minus_icon
What is today’s traded volume of Procept Biorobotics?
plus_minus_icon
What is today’s market capitalisation of Procept Biorobotics?
plus_minus_icon
What is the 52-Week High and Low Range of Procept Biorobotics?
plus_minus_icon
What percentage is Procept Biorobotics down from its 52-Week High?
plus_minus_icon
What percentage is Procept Biorobotics up from its 52-Week Low?
plus_minus_icon
Current Price
$51.1
$-0.69
(-1.33%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00